Specialty Pharmacy

Elderly patients with hepatitis C are typically difficult to treat due to poor tolerability and suboptimal response to interferon-based regimens.

A look at last week's top stories in the world of pharmacy.

Investigators seek to limit mother-to-child transmission of HIV without harming the immune development of infants.

Top news of the week from Specialty Pharmacy Times.

An advanced statistical modeling and analytic tool aims to improve personalized medicine through health care and medical data.

Anti-rheumatic drug suppresses activation of a molecular pathway responsible for the disease.

Targeted radiotherapy for breast cancer may improve overall quality of life and reduces side effects.

Top news of the day from across the health care landscape.

Many individuals at-risk of contracting HIV do not test routinely or have never been tested.

The National Association of Specialty Pharmacy expresses concern about fraud driving escalating drug costs.

Issues surrounding patents for curative drugs allow pharmaceutical companies to establish a market monopoly and charge astronomical prices.

The risk of gallbladder cancer was highest in women with a history of periodontal disease.

Four doses of PrEP around the time of sexual activity reduced HIV-infection risk by 97%.

Top news of the day from across the health care landscape.

Studying HER2-positive breast cancer at the cellular level may yield new treatments.

Rinku Patel, PharmD, RPh, CEO and founder of KloudScript, discusses the impact of direct and indirect remuneration (DIR) fees.

An estimated 2.7 million Americans have hepatitis C, too many for specialists to be the sole provider of anti-HCV therapy.

Pharmacy law conference, specialty certification exam prep course, and women in specialty luncheon highlight annual meeting and expo.

The upcoming National Association of Specialty Pharmacy annual meeting has unique offerings for attendees.

Naloxegol approved to treat opioid-induced constipation in patients with pain from previous treatment for cancer.

Housing Opportunities for Persons With AIDS program awarded $320.4 million to qualifying states and local jurisdictions.

Marcus H. Snow, MD, of the University of Nebraska Medical Center, discusses how education and counseling can improve the uptake of biosimilars among rheumatologists and patients.

Top news of the day from across the health care landscape.

Study findings highlight the importance of community-based health interventions that target cancer prevention.

Repatha combined with statin therapy may reduce cardiovascular events.

The launch of a second Remicade biosimilar could open the floodgates to biosimilar competition in the specialty drug market.

Approval sought for vemurafenib (Zelboraf) to treat Erdheim-Chester disease with BRAF V600 mutation.

Physical training further minimizes brain shrinkage in MS patients already receiving medication.